Display options
Cite
Mazza E, Maccario M, Ramunni J, et al. Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels. J Endocrinol Invest. 1999;22(9):681-7doi: 10.1007/BF03343629.
Mazza, E., Maccario, M., Ramunni, J., Gauna, C., Bertagna, A., Barberis, A. M., Patroncini, S., Messina, M., & Ghigo, E. (1999). Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels. Journal of endocrinological investigation, 22(9), 681-7. https://doi.org/10.1007/BF03343629
Mazza, E, et al. "Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels." Journal of endocrinological investigation vol. 22,9 (1999): 681-7. doi: https://doi.org/10.1007/BF03343629
Mazza E, Maccario M, Ramunni J, Gauna C, Bertagna A, Barberis AM, Patroncini S, Messina M, Ghigo E. Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels. J Endocrinol Invest. 1999 Oct;22(9):681-7. doi: 10.1007/BF03343629. PMID: 10595831.
Copy Download .nbib Format: NLM
Share it on

J Endocrinol Invest. 1999 Oct;22(9):681-7. doi: 10.1007/BF03343629.

Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels.

Journal of endocrinological investigation

E Mazza, M Maccario, J Ramunni, C Gauna, A Bertagna, A M Barberis, S Patroncini, M Messina, E Ghigo

Affiliations

  1. U.O. di Endocrinologia e, Ospedale Maria Vittoria, Torino, Italy.

PMID: 10595831 DOI: 10.1007/BF03343629

Abstract

Sex and age are the major determinants of serum levels of dehydroepiandrosterone sulfate (DHEA-S): they are about twice in men than in women and show a progressive reduction from the end of the puberty to aging in both sexes. It has been reported that DHEA-S levels are also negatively influenced by insulin. Moreover, DHEA-S levels reduction has been associated to increased risk for cardiovascular disease, which connotes hyperinsulinemic states, such as obesity. We have evaluated serum levels of DHEA-S and insulin as function of age and body mass index (BMI) in 376 adult women (age 18.1-89.6 yrs, median 42.2; BMI 15.7-57.8 kg/m2, median 32.7) by multiple regression and piecewise regression analysis. Insulin levels positively associated to BMI (p=0.000002) and DHEA-S levels negatively associated with age (p=0.000001). Considering the whole population, DHEA-S levels were related positively with BMI (p=0.0013) independently of age. DHEA-S were also directly related to insulin levels independently of age (p=0.042), but this association disappeared after correction for BMI. Piecewise regression analysis did not reveal a threshold level for the increase of BMI (p=0.0004). Interestingly, DHEA-S levels and BMI were positively associated before but not after menopause. Taking into account only obese population, (no.=143, age 18.7-67.3 yrs, mean 39.0, median 39.4) DHEA-S levels were again related negatively with age and positively with BMI, while were unrelated with waist to hip ratio (p=0.391). Our data show that increasing body mass and insulin secretion is not associated to DHEA-S reduction in women. This evidence suggests that DHEA-S is unlikely implicated in the pathogenesis of cardiovascular disease in obese women.

References

  1. Clin Endocrinol Metab. 1984 Nov;13(3):597-612 - PubMed
  2. J Clin Endocrinol Metab. 1995 Nov;80(11):3373-6 - PubMed
  3. Clin Endocrinol (Oxf). 1994 Oct;41(4):473-81 - PubMed
  4. J Clin Endocrinol Metab. 1992 Feb;74(2):362-7 - PubMed
  5. Horm Metab Res. 1988 Jan;20(1):57-60 - PubMed
  6. Ann Epidemiol. 1998 May;8(4):217-28 - PubMed
  7. J Clin Endocrinol Metab. 1994 Oct;79(4):1077-81 - PubMed
  8. J Endocrinol Invest. 1998 Feb;21(2):133-5 - PubMed
  9. J Clin Endocrinol Metab. 1993 Aug;77(2):341-6 - PubMed
  10. Lancet. 1995 May 13;345(8959):1193-4 - PubMed
  11. Fertil Steril. 1991 Sep;56(3):427-33 - PubMed
  12. Lancet. 1987 Apr 11;1(8537):821-4 - PubMed
  13. Metabolism. 1994 Jul;43(7):803-7 - PubMed
  14. J Clin Endocrinol Metab. 1994 Jun;78(6):1515-20 - PubMed
  15. J Clin Endocrinol Metab. 1995 Apr;80(4):1407-15 - PubMed
  16. J Clin Endocrinol Metab. 1987 Jan;64(1):180-4 - PubMed
  17. J Clin Endocrinol Metab. 1991 Apr;72(4):883-7 - PubMed
  18. J Clin Endocrinol Metab. 1995 Jul;80(7):2057-62 - PubMed
  19. J Endocrinol. 1996 Sep;150 Suppl:S149-53 - PubMed
  20. J Am Coll Cardiol. 1990 Nov;16(6):862-70 - PubMed
  21. J Clin Endocrinol Metab. 1996 Sep;81(9):3147-51 - PubMed
  22. J Clin Endocrinol Metab. 1994 Jun;78(6):1360-7 - PubMed
  23. J Clin Endocrinol Metab. 1984 Sep;59(3):551-5 - PubMed
  24. J Clin Endocrinol Metab. 1985 May;60(5):947-52 - PubMed
  25. Lancet. 1994 Jun 11;343(8911):1479-81 - PubMed
  26. J Clin Endocrinol Metab. 1988 Jan;66(1):57-61 - PubMed
  27. Clin Endocrinol (Oxf). 1995 Dec;43(6):665-9 - PubMed
  28. J Clin Endocrinol Metab. 1996 Mar;81(3):1173-8 - PubMed
  29. Am J Med. 1995 Jan 16;98(1A):40S-47S - PubMed
  30. J Endocrinol. 1995 Jul;146(1):63-9 - PubMed
  31. Clin Endocrinol (Oxf). 1999 May;50(5):595-600 - PubMed
  32. J Clin Endocrinol Metab. 1988 Jun;66(6):1329-31 - PubMed
  33. J Endocrinol Invest. 1998 Jun;21(6):399-401 - PubMed
  34. J Clin Endocrinol Metab. 1990 Oct;71(4):900-6 - PubMed
  35. J Clin Endocrinol Metab. 1997 Nov;82(11):3898-901 - PubMed
  36. J Clin Endocrinol Metab. 1996 Jan;81(1):59-64 - PubMed
  37. Metabolism. 1995 Apr;44(4):513-9 - PubMed
  38. Metabolism. 1994 May;43(5):599-603 - PubMed

Substances

MeSH terms

Publication Types